The price of Onivyde (nal-IRI) can vary significantly based on several factors, including insurance coverage, pharmacy, and the specific dosage prescribed. As a reference, a 30-day supply of Onivyde has been listed with prices around $9,700 to $10,000 [1].
How Does Insurance Affect Onivyde Pricing?
Insurance coverage plays a crucial role in the out-of-pocket cost of Onivyde for patients. Many patients may be eligible for financial assistance programs offered by the manufacturer, such as the Seagen, Inc. Patient Support Program, which can help reduce co-pay costs [1]. Eligibility for these programs typically depends on insurance status and residency.
What Factors Influence Onivyde's List Price?
The list price of Onivyde is influenced by the drug's development costs, manufacturing expenses, and the clinical value it provides in treating specific types of cancer. For instance, Onivyde is approved for patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy [2]. The specialized formulation and its targeted use contribute to its pricing.
When Might Onivyde's Price Change?
Changes in Onivyde's price could occur due to shifts in manufacturing costs, market demand, or the introduction of new clinical data supporting its efficacy. Additionally, patent expirations and the potential for generic competition in the future could impact pricing dynamics, although specific patent information for Onivyde should be consulted for exact timelines [3].
What Are the Costs Associated with Onivyde Treatment?
Beyond the drug's list price, patients may incur costs related to administration, such as infusion services. Physician visits and potential management of side effects also contribute to the overall treatment expense. It is advisable for patients to discuss all potential costs with their healthcare provider and insurance company.
Where Can I Find More Information on Drug Pricing and Patents?
For detailed information on drug pricing, patent status, and exclusivity timelines for Onivyde and other pharmaceuticals, resources like DrugPatentWatch.com are valuable [3]. This site provides data that can help understand market exclusivity and potential for generic entry.
What is Onivyde Used For?
Onivyde is a liposomal formulation of irinotecan used in combination with other chemotherapy agents to treat patients with metastatic adenocarcinoma of the pancreas. It is indicated for patients whose disease has progressed after or during treatment with gemcitabine-based chemotherapy [2].
---
Sources:
1. GoodRx, "Onivyde Price," https://www.goodrx.com/onivyde
2. National Cancer Institute, "Onivyde," https://www.cancer.gov/drugdictionary/drug-onivyde
3. DrugPatentWatch.com